It's a matter of time: Contemporary pre-hospital management of acute ST elevation myocardial infarction

Heart

Volumn 91, Issue 12, 2005, Pages 1524-1526

  Welsh, Robert C ^a,b   Armstrong, P W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY LIGATION; DEFIBRILLATOR; ELECTROCARDIOGRAPHY MONITORING; EMERGENCY HEALTH SERVICE; FIBRINOLYTIC THERAPY; HEART ARREST; HEART MUSCLE NECROSIS; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPERFUSION; RESUSCITATION; ST SEGMENT ELEVATION; SURVIVAL; TIME;

EMERGENCY MEDICAL SERVICES; GREAT BRITAIN; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 28144441131     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.055616     Document Type: Conference Paper

References (23)

1. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
2. Reimer KA, Lowe JE, Rasmussen MM, et al. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56:786-94.
3. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42.
4. Berger PB, Ellis SG, Holmes DR Jr, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO-IIb) trial. Circulation 1999;100:14-20.
5. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 2003;92:824-6.
6. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients witn acute myocardial infarction). Circulation 2004;110:588-636.
7. Armstrong PW, Bogaty P, Buller CE, et al. The 2004 ACC/AHA guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society working group. Can J Cardiol 2004;20:1075-9.
8. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 2003;24:94-104.
9. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003;108:2851-6.
10. Danchin N, Blanchard D, Steg PG, et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Circulation 2004;110:1909-15.
11. Taher T, Fu Y, Wagner GS, et al. Aborted myocardial infarction in patients with ST-segment elevation: insights from the assessment of the safety and efficacy of a new thrombolytic regimen-3 trial electrocardiographic substudy. J Am Coll Cardiol 2004;44:38-43.
12. Welsh RC, Ornato J, Armstrong PW. Prehospital management of acute ST-elevation myocardial infarction: a time for reappraisal in North America. Am Heart J 2003;145:1-8.
13. Luepker RV, Raczynski JM, Osganian S, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: the rapid early action for coronary treatment (REACT) trial. JAMA 2000;284:60-7.
14. Morrison LJ, Verbeek PR, McDonald AC, et al. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 2000;283:2686-92.
15. Morrow DA, Antman EM, Sayah A, et al. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of the early retavase-thrombolysis in myocardial infarction (ER-TIMI) 19 trial. J Am Coll Cardiol 2002;40:71-7.
16. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study, Lancet 2002;360:825-9.
17. Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT)-3 plus randomized trial in acute myocardial infarction. Circulation 2003;108:135-42.
18. Welsh RC, Goldstein P, Adgey J, et al. Variations in pre-hospital fibrinolysis process of care: insights from the assessment of the safety and efficacy of a new thrombolytic 3 plus international acute myocardial infarction pre-hospital care survey. Eur J Emerg Med 2004;11:134-40.
19. Welsh RC, Gordstein P, Chang WC, et al. Understanding time to treatment in AMI: insights from ASSENT 3 plus. Eur Heart J 2003;24(abstract supp):502.
20. Hirvonen TP, Halinen MO, Kala RA, et al. Delays in thrombolytic therapy for acute myocardial infarction in Finland. Results of a national thrombolytic therapy delay study. Finnish hospitals' thrombolysis survey group. Eur Heart J 1998;19:885-92.
21. Lambrew CT, Bowlby U, Rogers WJ, et al. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to thrombolysis substudy of the national registry of myocardial infarction-1. Arch Intern Med 1997;157:2577-82.
22. Goldberg RJ, Steg PG, Sadiq I, et al. Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). Am J Cardiol 2002;89(7):791-6.
23. Vaillancourt C, Stiell IG. Cardiac arrest care and emergency medical services in Canada. Can J Cardiol 2004;20:1081-90.